Biocept Inc (NASDAQ:BIOC)

0.8985
Delayed Data
As of Aug 14
 -0.1115 / -11.04%
Today’s Change
0.21
Today|||52-Week Range
1.30
+214.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues609.9K3.2M5.1M3.3M
 
 
 
 
 
Cost of Goods Sold4.3M6.6M8.8M9.3M
 
 
 
 
 
Depreciation And Amortization261.4K322.0K575.7K800.9K
 
 
 
 
 
 
Operating ExpensesGross Income-4.0M-3.7M-4.3M-6.8M
 
 
 
 
 
General Expenses12.4M14.3M16.9M17.5M
 
 
 
 
 
Research And Development2.9M2.7M3.4M4.5M
 
 
 
 
 
Total Operating Expenses17.0M21.2M26.2M27.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.4M-18.0M-21.2M-24.3M
 
 
 
 
 
Extraordinary Credit931.000.000.000.00
 
 
Interest Expense On Debt640.5K525.9K482.6K311.0K
 
 
 
 
 
Other Expenses102.4K153.7K51.2K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.9M-18.4M-21.6M-24.6M
 
 
 
 
 
Income Taxes-1.6K-2.1K-7.6K-1.9K
 
 
 
 
 
Preferred Dividend0.000.000.00-636.4K
 
 
Net Income-16.9M-18.4M-21.6M-24.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS183.8K319.3K908.2K2.8M
 
 
 
 
 
Shares To Calculate EPS Diluted183.8K319.3K908.2K2.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$91.80-$57.60-$23.70-$9.01
 
 
 
 
 
EPS Diluted-$91.80-$57.60-$23.70-$9.01